PAR paradigm biopharmaceuticals limited..

Rather than people ramping about Annual Reports Insights, it...

  1. 300 Posts.
    lightbulb Created with Sketch. 38
    Rather than people ramping about Annual Reports Insights, it truly is about time that people post facts about this stock rather than dribble and pipe dreams. Fiftyonecapital reported that Paul Rennie our CEO has himself been treated each year of the past 8 years under the SAS program! without treatment he conceded that around 6 years ago he would have likely needed a total knee replacement. We are very excited that his vision is now coming to life and millions of others will hopefully soon be living pain free. What an amazing story it is to be part of!

    Now we know why he has persevered with Paradigm because he was basically a human guinea pig in a controlled environment with a point to prove. This works no doubt whatsoever
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.5¢
Change
-0.015(3.49%)
Mkt cap ! $164.9M
Open High Low Value Volume
43.5¢ 44.0¢ 41.5¢ $216.2K 510.9K

Buyers (Bids)

No. Vol. Price($)
1 12344 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 2286 1
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.